XML 22 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 20,398 $ 19,713 $ 20,051
Operating expenses:      
Cost of sales 16,500 16,002 16,612
Selling, general and administrative 1,673 1,465 1,436
Amortization 208 211 233
Restructuring 185 193 211
Goodwill impairment 648 0 0
Total operating expenses 19,214 17,871 18,492
Operating income 1,184 1,842 1,559
Interest expense (361) (337) (285)
Other income (expense), net 50 41 63
Net gain on equity method transactions 46 605 0
Income before income taxes and equity loss 919 2,151 1,337
Income tax (expense) benefit (700) (223) 1,928
Income before equity loss 219 1,928 3,265
Equity loss, net of tax (38) (118) (299)
Net income 181 1,810 2,966
Net income attributable to noncontrolling interest 19 24 28
Net loss attributable to redeemable noncontrolling interest (3) (1) 0
Net income attributable to Aptiv 165 1,787 2,938
Mandatory convertible preferred share dividends 0 0 (29)
Net income attributable to ordinary shareholders $ 165 $ 1,787 $ 2,909
Basic net income per share:      
Basic net income per share attributable to ordinary shareholders $ 0.75 $ 6.97 $ 10.50
Weighted average ordinary shares outstanding, basic 220,000 256,380 276,920
Diluted net income per share:      
Diluted net income per share attributable to ordinary shareholders $ 0.75 $ 6.96 $ 10.39
Weighted average number of diluted shares outstanding 220,750 256,660 282,880